TP53 and leukemia: In this study, aberrations of TP53 were analyzed using next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH) in patients with Philadelphia chromosome-negative (Ph<sup>-</sup>) ALL enrolled in a prospective single-arm clinical trial at our leukemia center.